QC
DOUG icon

Quantessence Capital’s Douglas Elliman DOUG Stock Holding History

Quantessence Capital’s Portfolio DOUG Stock Details DOUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-29,292
Closed -$50.4K – 257
2025
Q1 		$50.4K Buy
+29,292
New +$53K 0.01% 323

Other funds holding DOUG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
MCM
Moerus Capital Management New York $271M AUM 58.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
THC
Truffle Hound Capital Bethesda, Maryland $386M AUM 57.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Quantessence Capital's DOUG Position: Q2 2025 in Review

Quantessence Capital sold out of Douglas Elliman (DOUG) in Q2 2025, closing a stake of 29,292 shares — an estimated $50.4K sold.

Quantessence Capital first reported a position in DOUG in Q1 2025 and held it in 1 quarter. The position peaked at $50.4K in Q1 2025. 134 funds tracked by Wall St. Rank hold DOUG as of Q2 2025.

  • Quantessence Capital reported no remaining Douglas Elliman position as of Q2 2025 after selling out during the quarter.
  • Quantessence Capital sold 29,292 Douglas Elliman shares in Q2 2025, an estimated $50.4K.
  • Quantessence Capital first reported a position in Douglas Elliman in Q1 2025 and held it in 1 quarter.
  • Quantessence Capital's Douglas Elliman position peaked at $50.4K in Q1 2025.
  • 134 funds tracked by Wall St. Rank held Douglas Elliman as of Q2 2025.

Based on Quantessence Capital's 13F filing for Q2 2025, filed 14 Aug 2025.